Sutro Biopharma, Inc. (STRO)
Sutro Biopharma Market Cap: 107.69M for Jan. 14, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| GT Biopharma, Inc. | 7.020M |
| Daré Bioscience, Inc. | 29.01M |
| Syndax Pharmaceuticals, Inc. | 1.863B |
| Crinetics Pharmaceuticals, Inc. | 5.262B |
| NovaBay Pharmaceuticals, Inc. | 1.603B |
Market Cap Related Metrics
| PS Ratio | 3.240 |
| PEG Ratio | -0.0007 |
| Price | 12.64 |
| Earnings Yield | -140.4% |
| PEGY Ratio | -0.0007 |